TITLE

Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

AUTHOR(S)
Wahlund, Lars-Olof; Julin, Per; Johansson, Sven-Erik; Scheltens, Philip
PUB. DATE
November 2000
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Nov2000, p630
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877759

 

Related Articles

  • Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. van de Pol, L. A.; Hensel, A.; van der Flier, W. M.; Visser, P-J.; Pijnenburg, Y. A. L.; Barkhof, F.; Gertz, H. Josef; Scheltens, P. // Journal of Neurology, Neurosurgery & Psychiatry;Apr2006, Vol. 77 Issue 4, p439 

    Background: Hippocampal atrophy on magnetic resonance imaging (MRI) is an early characteristic of Alzheimer's disease. However, hippocampal atrophy may also occur in other dementias, such as frontotemporal lobar degeneration (FTLD). Objective: To investigate hippocampal atrophy on MRI in FTLD...

  • Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. Scheltens, Philip; van de Pol, Laura // Journal of Neurology, Neurosurgery & Psychiatry;Nov2012, Vol. 83 Issue 11, p1038 

    The authors reflect on atrophy of medial temporal lobes including hippocampus on magnetic resonance imaging (MRI) in diagnosing Alzheimer's disease (AD). According to them medial temporal lobe atrophy visual rating (MTA) scores based on the height of the hippocampus and the width of the...

  • Widespread Neuronal Dysfunction in Temporal Lobe Epilepsy. Cascino, Gregory D. // Epilepsy Currents;Jan2003, Vol. 3 Issue 1, p31 

    Presents information on a study which characterized extrahippocampal metabolic abnormalities in medial temporal lobe epilepsy. Potential explanations for the widespread structural and metabolic abnormalities in patients with a localization-related epilepsy; Utilization of magnetic resonance...

  • Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population. Cavallin, Lena; Bronge, Lena; Yi Zhang; Øksenga° rd, Anne-Rita; Wahlund, Lars-Olof; Fratiglioni, Laura; Axelsson, Rimma // Acta Radiologica;Jun2012, Vol. 53 Issue 5, p573 

    Background: It is important to have a replicable easy method for monitoring atrophy progression in Alzheimer's disease. Volumetric methods for calculating hippocampal volume are time-consuming and commonly used in research. Visual assessments of medial temporal lobe atrophy (vaMTA) is a rapid...

  • Distinct functional MRI activations in the medial temporal lobe during encoding and retrieval of memories. Brewer, J.B. // Molecular Psychiatry;1997, Vol. 2 Issue 6, p427 

    Examines the distinct functional magnetic resonance imaging activations in the medial temporal lobe during encoding and retrieval of memories.

  • Temporal Lobe Volume in Disorders with Psychotic Features. Radonić, Elizabeta; Henigsberg, Neven; Radoš, Marko; Mimica, Ninoslav; Folnegović-Šmalc, Vera // Collegium Antropologicum;Jan2008 Supplement 1, Vol. 32, p139 

    Since early neuropathological findings, temporal lobe has been related to the pathophysiology of some disorders with psychotic features. The aim of this study was to compare temporal lobe volumes and asymmetry differences in patients with schizophrenia, schizoaffective and bipolar disorders,...

  • Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease? Boutet, Claire; Chupin, Marie; Colliot, Olivier; Sarazin, Marie; Mutlu, Gurkan; Drier, Aurélie; Pellot, Audrey; Dormont, Didier; Lehéricy, Stéphane // Neuroradiology;Dec2012, Vol. 54 Issue 12, p1321 

    Introduction: Hippocampus volumetry is a useful surrogate marker for the diagnosis of Alzheimer's disease (AD). Our purpose was to compare visual assessment of medial temporal lobe atrophy made by radiologists with automatic hippocampal volume and to compare their performances for the...

  • Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. Graff-Radford, Jonathan; Boeve, Bradley F.; Pedraza, Otto; Ferman, Tanis J.; Przybelski, Scott; Lesnick, Timothy G.; Vemuri, Prashanthi; Senjem, Matthew L.; Smith, Glenn E.; Knopman, David S.; Lowe, Val; Jack, Clifford R.; Petersen, Ronald C.; Kantarci, Kejal // Brain: A Journal of Neurology;Aug2012, Vol. 135 Issue 8, p2470 

    Acetylcholinesterase inhibitors are commonly used to treat patients with dementia with Lewy bodies. Hippocampal atrophy on magnetic resonance imaging and amyloid-β load on positron emission tomography are associated with the Alzheimer’s disease-related pathology in patients with...

  • Imaging Alzheimer in 2011. Hazewinkel, Marieke; Barkhof, Frederik // Neuroradiology;Sep2011, Vol. 53, p145 

    The article focuses on the use of diagnostic imaging in Alzheimer's Dementia (AD). Both magnetic resonance imaging (MRI) and computed tomography are sensitive enough to show medial temporal lobe atrophy and parietal atrophy. The proteins associated with AD, amyloid-beta and hyper-phosphorylated...

  • MRI can accurately ID early stage of Alzheimer's disease.  // Medical Technology & Devices Week;1/5/2009, Vol. 7 Issue 1, p1 

    The article focuses on a study conducted by the Florida Alzheimer's Disease Research Center in Miami which revealed that early magnetic resonance imaging (MRI) scans can detect shrinkage in certain regions of the brain to accurately diagnose Alzheimer's disease at a much earlier stage. Dr....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics